Cargando…
Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging
Drug resistance is an obstacle in the therapy of acute lymphoblastic leukemia (ALL). Whether the physical properties such as the motility of the cells contribute to the survival of ALL cells after drug treatment has recently been of increasing interest, as they could potentially allow the metastasis...
Autores principales: | Liu, Hsiao-Chuan, Gang, Eun Ji, Kim, Hye Na, Ruan, Yongsheng, Ogana, Heather, Wan, Zesheng, Bönig, Halvard, Shung, K. Kirk, Kim, Yong-Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349263/ https://www.ncbi.nlm.nih.gov/pubmed/32560076 http://dx.doi.org/10.3390/cells9061470 |
Ejemplares similares
-
Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies
por: Duchartre, Yann, et al.
Publicado: (2017) -
In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia
por: Ruan, Yongsheng, et al.
Publicado: (2022) -
Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
por: Kruse, Aaron, et al.
Publicado: (2020) -
Cadherins, Selectins, and Integrins in CAM-DR in Leukemia
por: Kim, Hye Na, et al.
Publicado: (2020) -
Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment
por: Ruan, Yongsheng, et al.
Publicado: (2020)